Bendamustine and Rituximab (BR) as Induction and Maintenance in Relapsed and Refractory Chronic Lymphocytic Leukemia
Clinical trial NCT03847727 · UNKNOWN
Trial details
- NCT number
- NCT03847727
- Sponsor
- Pirogov Russian National Research Medical University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2013-12-03
- Primary completion
- 2019-12-03
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.